Form 4: Arteris COO Sells 1,420 Shares Under 10b5-1 Plan

Arteris, Inc. Chief Operating Officer Laurent R. Moll reported the sale of 1,420 shares of common stock at $16.23 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Laurent R. Moll, Chief Operating Officer of Arteris, Inc. (AIP), reported a transaction involving the company's common stock.
• Moll disposed of 1,420 shares of common stock on January 6, 2026.
• The shares were sold at a price of $16.23 per share.
• Following this transaction, Moll beneficially owns 250,573 shares of Arteris, Inc. common stock.
• The transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by Moll on March 12, 2025.

Sentiment

Score: 5

Explanation: The sale of shares by a Chief Operating Officer is generally viewed as neutral to slightly negative. However, the execution under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic selling, suggesting a planned diversification or liquidity event rather than a lack of confidence in the company's future.

Positives

• The transaction was conducted under a Rule 10b5-1 trading plan, which indicates a pre-scheduled sale and helps mitigate concerns about opportunistic insider selling.

Negatives

• An insider sale, even if pre-planned, reduces the officer's direct equity stake in the company.

Stakeholder Impact

• Shareholders: A minor reduction in insider ownership, potentially interpreted as a slight negative, though mitigated by the 10b5-1 plan.

Key Dates

Keywords

Arteris, AIP, Form 4, insider trading, stock sale, beneficial ownership, Laurent R. Moll, Chief Operating Officer, 10b5-1 plan